J Gynecol Oncol.  2017 Jul;28(4):e52. 10.3802/jgo.2017.28.e52.

Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology

Affiliations
  • 1Department of Obstetrics and Gynecology, Tokai University School of Medicine, Isehara, Japan. mmikami@is.icc.u-tokai.ac.jp
  • 2Department of Obstetrics and Gynecology, Yamagata University School of Medicine, Yamagata, Japan.
  • 3Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
  • 4Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan.
  • 5Department of Obstetrics and Gynecology, Kumamoto University Graduate School of Medicine, Kumamoto, Japan.

Abstract


OBJECTIVE
Recent evidence has supported the concept that epithelial ovarian cancer (EOC) arises from the cells of the fallopian tube or endometrium. This study investigated current practice in Japan with respect to performing opportunistic bilateral salpingectomy (OBS) during gynecological surgery for benign disease for Ovarian Cancer Prevention.
METHODS
We mailed a questionnaire to 767 hospitals and clinics, comprising 628 accredited training institutions of the Japan Society of Obstetrics and Gynecology (JSOG), Japan Society of Gynecologic Oncology (JSGO), or Japan Society of Gynecologic and Obstetric Endoscopy and Minimally Invasive Therapy (JSGOE) and 139 private institutions with at least one JSGOE-certified licensed gynecologic laparoscopist.
RESULTS
Among the 767 institutions, 444 (57.9%) provided responses, including 91 (20.6%) that were both JSGOE and JSGO accredited, 71 (16.0%) that were only JSGO accredited, 88 (19.8%) that were only JSGOE accredited, and 194 (43.7%) that were unaccredited. It was found that awareness and performance of OBS largely depended on the JSGO and/or JSGOE accreditation status. OBS was only performed at 54.0% of responding institutions and just 6.8% of the institutions were willing to participate in randomized controlled trials to validate this method for reducing the incidence of ovarian cancer.
CONCLUSION
The JSOG Gynecologic Tumor Committee will announce its opinion on salpingectomy for ovarian cancer prevention to all JSOG members and will develop a system for monitoring the number of OBS procedures in Japan.

Keyword

Ovarian Neoplasms; Salpingectomy; Prevention & Control

MeSH Terms

Accreditation
Elective Surgical Procedures/utilization
Female
Genital Diseases, Female/surgery
*Gynecology
Hospitals, Teaching/standards/*statistics & numerical data
Humans
Japan
Neoplasms, Glandular and Epithelial/*prevention & control
*Obstetrics
Ovarian Neoplasms/*prevention & control
Randomized Controlled Trials as Topic
Salpingectomy/*utilization
*Societies, Medical
Surveys and Questionnaires
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr